Insulin Degludec/Liraglutide combination trial aims to compare efficacy and safety against monotherapies in Japanese T2DM
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.
Abstract
Insulin degludec/liraglutide combination efficacy and safety are compared to insulin degludec and liraglutide monotherapies in Japanese Type 2 Diabetes Mellitus patients.